World Market for Dialysis Equipment and Services

    Published: April 1, 2009 | Price: $995.00 – $7,000.00

    The dialysis industry enjoys a unique place in the healthcare sector. The industry encompasses two very lucrative segments -- the medical device industry (dialysis products and supplies segment) and the healthcare services industry (dialysis services segment). The dialysis industry remains a robust, multi-billion business that has managed to fuel its growth engine in the past 5 years. What makes this market more interesting and challenging is its relatively small customer base - only 1.8 million dialysis patients form its entire...
    Who’s Doing What in Molecular Diagnostics ? – The Results of the Kalorama Information/Emmes Group Survey of U.S. Laboratories

    Published: April 1, 2009 | Price: $1,500.00 – $9,990.00

    From Kalorama Information a unique tool for assessing the diagnostic business today. Working in conjunction with premier diagnostic survey database Emmes Group, Kalorama Information presents the summarized results from a recent survey of a critical mass of diagnostic labs in the U.S, with analysis from Kalorama's leading diagnostic analyst, Shara Rosen. Far more than any other market research report, this report provides the most current and accurate picture of what is truly going on in molecular diagnostics in the United...
    Wound Care Markets, 4th. Edition, Vol. I: Skin Ulcers

    Published: March 1, 2009 | Price: $995.00 – $5,990.00

    Wound care is a constantly changing market. The trend toward cost-effective skin ulcer treatment remains embedded in management programs that emphasize prevention and early intervention. New wound care products and devices are entering the market with lightening speed, all striving for the best clinical outcomes. Kalorama's Wound Care Markets, 4th Edition, Vol. I: Skin Ulcers. represents the fourth time that Kalorama has rexamined this aspect of the wound care market, and the study analyzes the market using the following product...
    Retail Clinics and the In-Store Healthcare Market 2009: Bright Spot in the Current Economy?

    Published: March 1, 2009 | Price: $1,995.00 – $7,000.00

    The appearance of in-store health clinics is a significant trend for pharmaceutical and POC diagnostic market watchers, as well as for those in retail. When last Kalorama published the first syndicated market research study on the emerging trend of in-store clinics in 2007, retail clinics were a novel trend. Now, with a few years of activity, they are established in food, drug, mass merchandizing and other stores, with both successes and failures. There is growth in some projects, scalebacks in...
    Liquid Chromatography Markets (LC, HPLC and UHPLC)

    Published: March 1, 2009 | Price: $1,995.00 – $3,990.00

    The liquid chromatography (LC) market has been relatively mature for quite a while, with a slow evolution of products and applications over the last few decades. High performance liquid chromatography (HPLC) has used essentially the same types of components since the 1980s. However, the market has seen an extraordinary amount of technological change in the last few years as companies have continued to introduce new systems performing fast LC and ultra HPLC (UHPLC). This report, Liquid Chromatography Markets,, represents Kalorama's...
    Contract Manufacturing in Orthopedics Devices: Markets for Hip and Knee Implants

    Published: February 1, 2009 | Price: $995.00 – $3,000.00

    This Kalorama report, Contract Manufacturing in Orthopedics Devices: Markets for Hip and Knee Implants provides market size and forecast for the most utilized orthopedic devices. A global report, the business is calculated and forecasted for the United States, Europe, Asia and Rest of World. This report should be of interest to both the established and new entrant CM’s that are engaged in customer retention with existing revenues and established business, or generating new revenue streams from the high growth medical...
    Clinical Nutrition Products: World Markets, 3rd Edition

    Published: February 1, 2009 | Price: $3,995.00 – $7,590.00

    This Kalorama Information report - Clinical Nutrition - focuses on three primary segments of essential medical nutrition: Infant Nutrition: (Milk-based, Soy-based, Special Needs such as Chronic Reflux or Gastrointestinal Discomfort) Enteral Nutrition (Standard and Fiber-containing Elemental and Semi-elemental, Specialized for Chronically Ill Patients) Parenteral Nutrition For each category, the report provides revenue data and forecasts for the most important segmentations. The report includes incidence of conditions which often require enteral or parenteral feeding, birth rates, over 65 population, and overall...
    Women’s Health: Worldwide Prescription Drug Markets

    Published: February 1, 2009 | Price: $995.00 – $5,990.00

    Women’s health encompasses all different areas of medicine and it would be a monumental task to address all of the areas that affect women. This report will concentrate on disorders that affect the female reproductive system and other disorders where there is at least a 70% preponderance of women affected by the disorder. The worldwide prescription drug market for women’s health consists of total manufacturers’ revenues from the following product categories: Autoimmune diseases Cancer Gynecological and Sexually Transmitted Diseases Hormones...
    Stem Cell Therapeutics Markets

    Published: February 1, 2009 | Price: $995.00 – $5,000.00

    Political and business events presage change for stem cell therapeutics, most notably the expected move by President Barack Obama to lift federal funding restrictions on stem-cell research. The U.S. Congress has also indicated a desire to move forward with stem cell research. The momentum in two branches of American government, along with scientific developments and the competition of world markets presages good market conditions for stem cell research. With their ability to differentiate and become an ongoing source of cells...
    Medical Imaging Markets, Volume I: Radiography (X-Ray, Digital X-Ray, Fluoroscopy, Mammography, and CT Markets)

    Published: February 1, 2009 | Price: $1,500.00 – $7,000.00

    The reinvigorated market for medical imaging systems employing x-rays has undoubtedly been propelled by the explosion of digital technology. But also, the expanded role of imaging modalities in a whole host of clinical applications from trauma to cancer to cardiology has increased the profile of radiography while enabling computer technologies expand the usefulness of traditional x-ray techniques. Kalorama's Medical Imaging Markets Volume I: Radiography analyzes the current and potential world market for medical x-ray systems, including several distinct imaging modalities...
    Medical Beds and Medical Chairs

    Published: February 1, 2009 | Price: $2,995.00 – $5,990.00

    This report provides the reader with an overview of the medical beds and medical chairs industry and the trends driving growth. Medical beds include all hospital types of beds including mattresses and overlays. The term medical chairs can refer to many different types of chairs including ENT chairs, examination chairs, blood drawing chairs, cardiac chairs, dialysis chairs, ophthalmic chairs, surgery chairs and many more. For the purposes of this report, only rehabilitation chairs and wheelchairs are considered in the market...
    Pharmaceutical Markets in Russia

    Published: January 1, 2009 | Price: $995.00 – $1,990.00

    The pharmaceutical market in Russia ranks among the top twenty markets in the world with the potential to move up in ranking rather quickly. This market will be one of several that major pharmaceutical companies are exploring for new opportunities for growth. Reliance on commodity prices makes Russia's economy and government spending on healthcare variable, but awareness of healthcare issues, especially among the younger population, and a willingness to spend personal funds on healthcare will drive Russian markets. For the...
    Nosocomial Infections: Market Impact on Diagnostics and Therapeutics: (MRSA, HAP, C. diff and other Hospital Acquired Infections)

    Published: January 1, 2009 | Price: $3,500.00 – $7,000.00

    A nosocomial, or hospital-acquired, infection is a new infection that is usually defined as an infection that is identified at least forty-eight to seventy-two hours following admission, This type of infection is also known as a hospital-acquired infection (or more generically healthcare-associated infections). Marketing planners in the pharmaceutical or diagnostic industries should have an understanding of the market impact of nosocomial infections, as it will be an important consideration in these markets into the near future. This report. Hospital Acquired...
    World Market for Molecular Diagnostics, 3rd. Edition (Infectious Disease, Oncology, Blood Screening, Pre-Natal and Other Areas)

    Published: January 1, 2009 | Price: $3,995.00 – $7,990.00

    Molecular diagnostics represents a revolution postponed, perhaps, but one that is now clearly underway. DNA Testing has emerged fully from research into clinical practice and becoming a dominant platform in clinical medicine. From Emerging to Emergent Technology Instrumentation now automates many of the sample preparation and assay steps that were formerly labor intensive. New tests are being launched all the time. At each step of the way, Kalorama Information has reported on its progress, and in this latest market research...
    Pharmaceutical Outsourcing Post-Launch : Contract Manufacturing, Biomanufacturing and Sales, 3rd Edition

    Published: January 1, 2009 | Price: $995.00 – $7,000.00

    This report is focused on two expanding pharmaceutical outsourcing markets, contract manufacturing of prescription drugs and contract sales and marketing. Both markets represent excellent post launch outsourcing opportunities for companies competing in this fast growing pharmaceutical outsourcing sector. A major factor driving the upward trend in the number of manufacturing projects being outsourced is that specialized production, i.e., sterile manufacturing, biopharmaceutical manufacturing and specialized processes, such as chiral chemistry and improvements in catalyst activity, is often not included in the...